Whatever we say about these hearings, Rep. Paul Kanjorski (D, Penn.) asks a few key questions that have heretofore escaped serious attention: who, beyond the baseball-industrial-complex, is profiting from steroids? Who’s making these steroids? What role, if any, does the international pharmaceutical industry play in the proliferation of steroids? How can steroid production be used to measure steroid abuse? The answers don’t appear to be simple, but they bear exploration. Follow the money.